Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Weihao ZhengDivision of Experimental Medicine, Department of Medicine, University of California, San Francisco, California, USA.ORCID 0000-0002-8038-1207
Jason D LimberisDivision of Experimental Medicine, Department of Medicine, University of California, San Francisco, California, USA.ORCID 0000-0002-7893-8416
Zachary P HowardDivision of Experimental Medicine, Department of Medicine, University of California, San Francisco, California, USA.ORCID 0000-0002-1958-4638
Alex MohapatraDivision of Experimental Medicine, Department of Medicine, University of California, San Francisco, California, USA.ORCID 0000-0003-0400-6146
Enzo TakagiDivision of Nephrology, Department of Medicine, University of California, San Francisco, California, USA.
Joel D ErnstDivision of Experimental Medicine, Department of Medicine, University of California, San Francisco, California, USA.ORCID 0000-0001-9951-6207
Funding
MUTIDISCIPLINARY TRAINING PROGRAM IN LUNG DISEASEST32HL007185 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI David J Erle, LAURENCE HUANG · 1985 to 2026
$24.6M
Initiation of the Immune Response to M. tuberculosisR01AI051242 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ERNST, JOEL D. · 2002 to 2019
$8.3M
Microbial Pathogenesis and Host DefenseT32AI060537 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Joanne N. Engel · 2004 to 2026
$6.5M
Functional dynamics of TB granuloma architecture - Diversity Supplement for Kelley J. MartinezU01AI166309 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Joel D. Ernst · 2022 to 2026
$3.2M
Tuberculosis Research and Mentorship Program (TB RAMP II)R25AI147375 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Elizabeth Fair, PAYAM NAHID · 2020 to 2026
$2.8M
Mechanistic investigation of differential T cell responses to distinct Mycobacterium tuberculosis antigensF31AI172360 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HOWARD, ZACHARY · 2022 to 2024
$132k
Impact of Mycobacterium tuberculosis on monocyte differentiation in vivoF32HL162424 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MOHAPATRA, ALEXANDER · 2023 to 2023
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Impaired IFNγ responsiveness of monocyte-derived lung cells limits immunity to · full record | OpenQuestion